Standardizing warfarin care can achieve high therapeutic times

In this retrospective analysis of a national standardized approach to warfarin treatment in Sweden, with care coordination and online standardized dosing algorithms, the mean time within therapeutic range was 76% for all patients, which is much higher than current standard practice, or most clinical trials. It is encouraging that widespread standardization of warfarin dosing/treatment can achieve high levels of therapeutic levels (abstract)

Danielle Scheurer

Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.

Leave a Comment